Charles Evan Ballantyne - Apr 10, 2023 Form 3 Insider Report for Gain Therapeutics, Inc. (GANX)

Signature
/s/ Cathy Rude, Attorney-in-Fact
Stock symbol
GANX
Transactions as of
Apr 10, 2023
Transactions value $
$0
Form type
3
Date filed
4/12/2023, 05:35 PM

No securities are beneficially owned.

Remarks:

No securities are beneficially owned. Exhibit List - Exhibit 24 - Power of Attorney